Best Options Strategy for DXCM
Looking for the best options strategy for Dexcom (DXCM)? There is no single answer — the right play depends on your outlook, your risk tolerance and current implied volatility. Below, our free engine shows the highest-scoring defined-risk strategy on the live DXCM option chain right now, and a simple map from your view on DXCM to the strategy that fits it. Model any of them in the calculator before you trade.
About DXCM
Dexcom (DXCM) is a major company in continuous glucose monitors. Options traders on DXCM tend to watch device demand, competition and earnings, since these can drive large moves in the share price.
DXCM for options traders
Dexcom is a pure-play continuous glucose monitor (CGM) maker, and that narrow focus is exactly what keeps its implied volatility (IV) structurally elevated. The stock is acutely sensitive to earnings surprises — guidance changes around patient adoption, reimbursement coverage, and international expansion routinely produce large single-session moves. Competitive pressure from rival CGM platforms and any shift in Medicare or insurance policy can reprice the stock abruptly, making IV spike well outside of earnings windows too.
Options liquidity is solid for a mid-cap medical-device name, with enough open interest across near-dated strikes to support multi-leg structures. Long straddles and strangles are popular into earnings given the history of outsized moves in either direction. Between catalysts, when IV retreats, premium sellers often deploy iron condors or short strangles to harvest elevated time value within an expected trading range. Defined-risk spreads — vertical calls or puts — suit traders with a directional lean who want to manage the cost of exposure on a name that can gap sharply.
Today's top-scoring strategy for DXCM
Our engine ranks defined-risk strategies on the live DXCM chain by probability of profit and risk/reward, then surfaces the best-scoring one. It is an educational illustration, not advice.
| Action | Qty | Type | Strike | Premium |
|---|---|---|---|---|
| Buy | 1× | CALL | $95 | $9.14 |
| Sell | 2× | CALL | $100 | $6.44 |
| Buy | 1× | CALL | $105 | $4.37 |
Simulation
Forward simulation of 6,000 lognormal price paths to expiration — not a historical backtest.
Strategy analysis
Greeks vs price
Price × volatility (today)
| −30% | −15% | IV | +15% | +30% | |
|---|---|---|---|---|---|
| $125 | −$49 | −$41 | −$37 | −$34 | −$33 |
| $120 | −$37 | −$30 | −$27 | −$26 | −$27 |
| $115 | −$19 | −$16 | −$17 | −$19 | −$22 |
| $110 | $2 | −$3 | −$8 | −$13 | −$17 |
| $105 | $20 | $8 | −$1 | −$9 | −$14 |
| $100 | $26 | $11 | $0 | −$8 | −$14 |
| $95 | $16 | $4 | −$4 | −$11 | −$17 |
| $90 | −$8 | −$11 | −$15 | −$19 | −$22 |
| $85 | −$33 | −$29 | −$28 | −$29 | −$30 |
| $80 | −$51 | −$45 | −$41 | −$39 | −$38 |
| $75 | −$60 | −$56 | −$52 | −$49 | −$47 |
Illustrative example at DXCM's latest available price, computed with the same engine as the tool. Live option fills and the real IV skew refresh during US market hours.
Implied volatility
DXCM typically trades with elevated implied volatility, so its options carry richer premiums. Implied volatility drives option prices, so it is worth checking the live chain before you trade.
Earnings & IV crush
DXCM's next earnings report is due around July 30, 2026. Options that expire after it price in a binary move, so their implied volatility is elevated and usually collapses right after the announcement — an "IV crush". If your expiration falls before this date, the trade sidesteps the event.
Key figures
- Market cap
- $29.6B
- Beta (vs market)
- 1.45
- 52-week range
- $54.11–$89.98
- Short interest
- 5.4% of float · 3.4 days to cover
How to choose an options strategy for DXCM
Start with your outlook on DXCM, then match it to a defined-risk structure. Here are the most common choices and when each makes sense:
Bullish
Buy a call for leverage with capped risk, or a bull call spread to lower the cost and breakeven when you have a target price.
Long Call → Bull Call Spread →Bearish
Buy a put to profit from a decline with defined risk, or a bear put spread to cheapen the trade when you expect a measured move down.
Long Put → Bear Put Spread →Neutral
Sell an iron condor to collect premium while DXCM stays between two strikes, or write a covered call against shares you already own.
Iron Condor → Covered Call →How we pick the best strategy
For each ticker we pull the live option chain, build every supported strategy around the at-the-money strikes, and score them on probability of profit, risk/reward and capital efficiency — favouring defined-risk structures where the maximum loss is known up front. Methodology →
Open DXCM in the free calculator →
Frequently asked questions
What is the best options strategy for DXCM?
It depends on your outlook. Bullish traders often use a long call or bull call spread on DXCM; bearish traders a long put or bear put spread; neutral traders an iron condor or covered call. Our live scan above shows the current highest-scoring defined-risk play.
Are DXCM options liquid enough to trade?
Dexcom (DXCM) is among the most actively-traded US options, which usually means tight bid/ask spreads and plenty of strikes and expirations — though you should always check the open interest and spread on the exact contract.
How much money do I need to trade DXCM options?
Buying a single DXCM call or put can cost as little as the premium (often one to a few hundred dollars), while income strategies like a cash-secured put need enough capital to buy 100 shares if assigned.
Is this financial advice?
No. Everything here is educational and uses delayed, third-party data. It is not a recommendation to trade DXCM or any security. Do your own research.
What does Dexcom do?
Dexcom (DXCM) operates in the Medical Devices industry. The "About Dexcom" section above gives a fuller picture of what the company does and how it earns money.
Does Dexcom pay a dividend?
We don't show a confirmed dividend yield for Dexcom here, so treat it as uncertain: before writing calls, check its current dividend and ex-dividend date with your broker — an approaching ex-dividend date can trigger early assignment on in-the-money short calls.
When does Dexcom next report earnings?
Dexcom's next earnings are expected around July 30, 2026. Implied volatility usually climbs into the report and drops sharply afterwards (IV crush) — important for any options position held over the date.
Tickers related to DXCM
Comparing DXCM with similar names can help you choose the best options strategy:
Company information
- Headquarters
- 6340 Sequence Drive, San Diego, CA, 92121, United States
- Industry
- Medical Devices
- Employees
- 11,000
- CEO
- Mr. Jacob Steven Leach
- Phone
- 858 200 0200
- Website
- www.dexcom.com
- Investor relations
- www.dexcom.com/about-dexcom/investor-relations
Best Options Strategy by Ticker →
Educational use only. Quotes are delayed ~15 minutes and nothing here is financial advice. Options trading involves substantial risk of loss. Privacy · Terms.